FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980219977> ?p ?o ?g. }

• W1980219977 endingPage "1161" @default.
• W1980219977 startingPage "1147" @default.
• W1980219977 abstract "The Janus family kinases (JAKs), JAK1, JAK2, JAK3, and TYK2, are involved in cell growth, survival, development, and differentiation of a variety of cells, particularly immune cells and hematopoietic cells. They form a subgroup of the non-receptor protein tyrosine kinases. Activating mutations within each of the JAKs is associated with malignant transformations; the most common are mutations of JAK2 in polycythemia vera (PV) and other myeloproliferative neoplasms (MPN). Identification of the V617F mutation of the JAK2 gene (JAK2 V617F) led to an important breakthrough in the understanding of MPN disease pathogenesis. The JAK2 V617F mutation is present in the majority of PV patients, and about 50% of patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF) are affected. This mutation leads to hyperactivation of JAK2, cytokine-independent signaling, and subsequent activation of downstream signaling networks. JAK2 ATP-competitive inhibitors that indirectly inhibit the JAK-STAT pathway are new candidates for the treatment of MPN. JAK2 inhibitors in development for the treatment of MPN have demonstrated clinical activity with minimal toxicity. These agents consistently alleviate constitutional symptoms and reduce spleen size in PMF and other MPN. However, some of these inhibitors have additional unique effects. Ruxolitinib causes a significant reduction in the level of pro-inflammatory cytokines. Another inhibitor, CYT387, improves anemia. Many other JAK2 inhibitors such as TG101348 or SAR302503, SB1518, CEP701 and LY2784544 are now under investigation for MPN development. In contrast tasocitinib, a predominantly JAK3 inhibitor, is being evaluated in a number of inflammatory and immunological diseases, including rheumatoid arthritis, psoriasis, ulcerative colitis, dry eye disease and in kidney transplant patients. In conclusion the use of JAK inhibitors in MPN and some of the immune-mediated disorders is a promising new strategy for therapy. However, definitive data from ongoing and future preclinical and clinical trials will aid in better defining the status of these drugs in the treatment of these diseases." @default.
• W1980219977 created "2016-06-24" @default.
• W1980219977 creator A5005053658 @default.
• W1980219977 creator A5087571749 @default.
• W1980219977 date "2013-02-01" @default.
• W1980219977 modified "2023-09-27" @default.
• W1980219977 title "JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms" @default.
• W1980219977 doi "https://doi.org/10.2174/0929867311320090004" @default.
• W1980219977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23317159" @default.
• W1980219977 hasPublicationYear "2013" @default.
• W1980219977 type Work @default.
• W1980219977 sameAs 1980219977 @default.
• W1980219977 citedByCount "20" @default.
• W1980219977 countsByYear W19802199772013 @default.
• W1980219977 countsByYear W19802199772015 @default.
• W1980219977 countsByYear W19802199772016 @default.
• W1980219977 countsByYear W19802199772017 @default.
• W1980219977 countsByYear W19802199772018 @default.
• W1980219977 countsByYear W19802199772020 @default.
• W1980219977 countsByYear W19802199772021 @default.
• W1980219977 countsByYear W19802199772022 @default.
• W1980219977 crossrefType "journal-article" @default.
• W1980219977 hasAuthorship W1980219977A5005053658 @default.
• W1980219977 hasAuthorship W1980219977A5087571749 @default.
• W1980219977 hasConcept C112392421 @default.
• W1980219977 hasConcept C126322002 @default.
• W1980219977 hasConcept C130523297 @default.
• W1980219977 hasConcept C170493617 @default.
• W1980219977 hasConcept C180361614 @default.
• W1980219977 hasConcept C203014093 @default.
• W1980219977 hasConcept C2775960820 @default.
• W1980219977 hasConcept C2776112149 @default.
• W1980219977 hasConcept C2778690821 @default.
• W1980219977 hasConcept C2778837598 @default.
• W1980219977 hasConcept C2780007613 @default.
• W1980219977 hasConcept C2780076729 @default.
• W1980219977 hasConcept C2781057849 @default.
• W1980219977 hasConcept C2781107747 @default.
• W1980219977 hasConcept C32465701 @default.
• W1980219977 hasConcept C502942594 @default.
• W1980219977 hasConcept C71924100 @default.
• W1980219977 hasConcept C86803240 @default.
• W1980219977 hasConceptScore W1980219977C112392421 @default.
• W1980219977 hasConceptScore W1980219977C126322002 @default.
• W1980219977 hasConceptScore W1980219977C130523297 @default.
• W1980219977 hasConceptScore W1980219977C170493617 @default.
• W1980219977 hasConceptScore W1980219977C180361614 @default.
• W1980219977 hasConceptScore W1980219977C203014093 @default.
• W1980219977 hasConceptScore W1980219977C2775960820 @default.
• W1980219977 hasConceptScore W1980219977C2776112149 @default.
• W1980219977 hasConceptScore W1980219977C2778690821 @default.
• W1980219977 hasConceptScore W1980219977C2778837598 @default.
• W1980219977 hasConceptScore W1980219977C2780007613 @default.
• W1980219977 hasConceptScore W1980219977C2780076729 @default.
• W1980219977 hasConceptScore W1980219977C2781057849 @default.
• W1980219977 hasConceptScore W1980219977C2781107747 @default.
• W1980219977 hasConceptScore W1980219977C32465701 @default.
• W1980219977 hasConceptScore W1980219977C502942594 @default.
• W1980219977 hasConceptScore W1980219977C71924100 @default.
• W1980219977 hasConceptScore W1980219977C86803240 @default.
• W1980219977 hasIssue "9" @default.
• W1980219977 hasLocation W19802199771 @default.
• W1980219977 hasLocation W19802199772 @default.
• W1980219977 hasOpenAccess W1980219977 @default.
• W1980219977 hasPrimaryLocation W19802199771 @default.
• W1980219977 hasRelatedWork W1543124619 @default.
• W1980219977 hasRelatedWork W1825604416 @default.
• W1980219977 hasRelatedWork W1980219977 @default.
• W1980219977 hasRelatedWork W2116650111 @default.
• W1980219977 hasRelatedWork W2137226206 @default.
• W1980219977 hasRelatedWork W2143141179 @default.
• W1980219977 hasRelatedWork W2394674019 @default.
• W1980219977 hasRelatedWork W2768585710 @default.
• W1980219977 hasRelatedWork W3081450346 @default.
• W1980219977 hasRelatedWork W4246545933 @default.
• W1980219977 hasVolume "20" @default.
• W1980219977 isParatext "false" @default.
• W1980219977 isRetracted "false" @default.
• W1980219977 magId "1980219977" @default.
• W1980219977 workType "article" @default.